Recorded Program
Read the Opinions of Our Experts
Proven Approaches to Preventing Hypoglycemia
Brian Frier, BSc, MD, FRCP(Edin)
Edinburgh, Scotland, United Kingdom
01/11/2021
Fixed-dose Combinations in the Management of Type 2 Diabetes
Abdullah Bennakhi, MD
Kuwait City, Kuwait
01/13/2021
The Impact of Uncontrolled Diabetes on Overall Cardiovascular Health
Naveed Sattar, MD
Glasgow, Scotland, United Kingdom
01/19/2021
The Global Burden of Diabetes: Challenges and Advances
Andrew JM Boulton, MD, DSc, FICP, FACP, FRCP
Manchester, England, United Kingdom
01/20/2021
New Type 2 Diabetes Treatment Options: Optimizing Results Amidst the COVID-19 Pandemic
Shashank R. Joshi, MD, DM, FRCP, FACE, FACP, FICP, FICN
Mumbai, Maharashtra, India
01/23/2021
Program Information
The treatment of type 2 diabetes mellitus has evolved in the present century toward safer and more effective treatments, which in some cases can also reduce the risk of hypoglycemia, cardiovascular disease and renal outcomes. New glucose-lowering drugs acting on novel pathways, as well as new formulations, have been developed, licensed and launched, many of which provide new options for the management of type 2 diabetes. However, there is a rising prevalence of type 2 diabetes and its associated comorbidities, posing new challenges for health care practitioners. These challenges are that much more demanding during the unprecedented COVID-19 pandemic.
This interactive webinar will review the novel mechanisms of action and pharmacokinetics of these agents and will also address how reaching appropriate therapeutic goals for the type 2 diabetes patient is possible. Four short presentations by prominent leaders in the fields of endocrinology and cardiology will focus on topics that will enable practitioners to implement new therapeutic strategies.
Learning Objectives
Based on the information presented during this live program, upon the webinar’s conclusion participants will be able to:
- Recognize the association between glycemic variability as a predictor of hypoglycemia, the clinical implications of hypoglycemia in type 2 diabetes patients, and proven approaches to its prevention
- Explain the role of fixed dose combination therapy and when and how it is appropriate to adjust insulin therapy in type 2 diabetes patients, as well as manage clinical inertia
- Implement new treatment strategies with evidence provided by recent cardiovascular outcomes trials that highlight new therapies that have a demonstrated decrease in cardiovascular risk
- Understand the special considerations for patients with type 2 diabetes in light of the COVID-19 pandemic
Meet the Faculty
Andrew J.M. Boulton, MD, DSc, FICP, FACP, FRCP (Program Chair)
Professor of Medicine, University of Manchester and
Consultant Physician, Manchester Royal Infirmary
Manchester, England, United Kingdom
Visiting Professor of Medicine, University of Miami Miller School of Medicine
Miami, Florida, United States
Chairman, EURADIA (The European Alliance for Diabetes Research)
President, International Diabetes Federation
Member of the Board of Directors, Worldwide Initiative for Diabetes Education
Brian M. Frier, BSc, MD, FRCP(Edin)
Honorary Professor of Diabetes
BHF Centre for Cardiovascular Science
The Queen’s Medical Research Institute
University of Edinburgh
Edinburgh, Scotland, United Kingdom
Abdullah Bennakhi, MD
Consultant Physician Diabetologist
Chair of the Regulatory Affairs Office and Ethical Review Committee
Dasman Diabetes Institute
Kuwait City, Kuwait
Naveed Sattar, MD
Professor/Honorary Consultant
Cardiovascular & Medical Sciences
University of Glasgow
Glasgow, Scotland, United Kingdom
Shashank R. Joshi, MD, DM, FRCP, FACE, FACP, FICP, FICN
Professor and Senior Consultant
Lilavati Hospital
Mumbai University
Mumbai, Maharashtra, India
Webinar Agenda
| Time | Presentation | Speaker |
| 20:00 – 20:05 | Introduction and Program Objectives | Andrew J.M. Boulton, MD, DSc, FICP, FACP, FRCP (Chair) |
| 20:05 – 20:20 | Proven Approaches to Preventing Hypoglycemia | Brian Frier, BSc, MD, FRCP(Edin) |
| 20:20 – 20:35 | Fixed Dose Combinations and Other Strategies to Managing Type 2 Diabetes | Abdullah Bennakhi, MD |
| 20:35 – 20:50 | The Impact of Uncontrolled Type 2 Diabetes on Overall Cardiovascular Health | Naveed Sattar, MD |
| 20:50 – 21:05 | New Type 2 Diabetes Treatment Options: Optimizing Results Amidst the COVID-19 Pandemic | Shashank Joshi, MD, DM, FRCP, FACE |
| 21:05 – 21:20 | Live Discussion of Questions Submitted per Worldwide Diabetes-IFM Pre-Webinar Blog | Moderated by the webinar chair |
| 21:20 – 21:30 | Panel Discussion / Question & Answer Session | All Speakers |
This program is sponsored by the Worldwide Initiative for Diabetes Education and supported by an educational grant from Novo Nordisk A/S.
